RESVERLOGIX CORP by Resverlogix Corp. (RVXCF) Stock Price, Quote, News & History

RVXCFOTCPK

Trade with Public

$0.0495

-0.0187-27.42%

At close: Aug 28, 5:00 PM EST

OverviewNews Financials Sentiment Compare

Key Statistics

Open

$0.05

Volume / Avg.

1.30K / 29.40K

Day Range

$0.05 - $0.05

52 Wk Range

0.05 - 0.10

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

2.63

Recent Resverlogix Corp News

Stocks That Hit 52-Week Lows On Monday

Lisa Levin

Stocks That Hit 52-Week Highs On Tuesday

Benzinga Insights

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-3.77M

Investing Cash Flow (TTM)

-647.00K

Financing Cash Flow (TTM)

4.49M

Free Cash Flow (TTM)

-4.44M

Capital Expenditure (TTM)

-668.00K

Net Change in Cash (TTM)

70.00K

Valuation Metrics

Enterprise Value

$44.68M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

-58.65%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.27

Company Debt

Total Debt

$21.10M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$80.00K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.05

Volume / Avg.

1.30K / 29.40K

Day Range

$0.05 - $0.05

52 Wk Range

0.05 - 0.10

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

2.63

About

Sector

Health Care

Industry

Biotechnology

Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra-terminal) inhibitor. BET bromodomain inhibition is an epigenetic m...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

RVXCF

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

RVXCF

FAQ

How do I buy RESVERLOGIX CORP by Resverlogix Corp. (RVXCF) stock?

You can purchase shares of RESVERLOGIX CORP by Resverlogix Corp. (OTCPK:RVXCF) through any online brokerage.

View our list of the best stock brokerages

Who are RESVERLOGIX CORP by Resverlogix Corp. (RVXCF) competitors?

There are no as such competitors for RESVERLOGIX CORP by Resverlogix Corp..

What is the forecast, or price target, for RESVERLOGIX CORP by Resverlogix Corp. (RVXCF) stock?

There is no analysis for RESVERLOGIX CORP by Resverlogix Corp. to provide a consensus price target.

What is the current price for RESVERLOGIX CORP by Resverlogix Corp. (RVXCF)?

The stock price for RESVERLOGIX CORP by Resverlogix Corp. (OTCPK: RVXCF) is $0.0495 last updated August 28, 2026 at 9:30 AM EDT.

Does RESVERLOGIX CORP by Resverlogix Corp. (RVXCF) pay a dividend?

There are no upcoming dividends for RESVERLOGIX CORP by Resverlogix Corp..

When is RESVERLOGIX CORP by Resverlogix Corp. (OTCPK:RVXCF) reporting earnings?

RESVERLOGIX CORP by Resverlogix Corp. does not have any upcoming earnings scheduled.

Is RESVERLOGIX CORP by Resverlogix Corp. (RVXCF) going to split?

There is no upcoming split for RESVERLOGIX CORP by Resverlogix Corp..

What sector and industry does RESVERLOGIX CORP by Resverlogix Corp. (RVXCF) operate in?

RESVERLOGIX CORP by Resverlogix Corp. is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.